Provided by Tiger Trade Technology Pte. Ltd.

ETF & Stock Investment

2,075.69
+17.030.83%
Number of Gainers:618
Number of Losers:389
Number of Flat:17
PE:- -
High:2,083.23
Open:2,058.90
Low:2,058.90
Close:2,058.66
Volume:6.00B
Turnover:741.53B
Market Cap:96.63T
Float Cap:90.45T

Loading ...

Morgan Stanley Adjusts Price Target on Invesco to $31 From $30, Keeps Equalweight Rating

MT Newswires Live
·
Sep 25

Morgan Stanley Adjusts Price Target on T. Rowe Price to $110 From $116, Keeps Equalweight Rating

MT Newswires Live
·
Sep 25

US Treasury Yields Breach 5%: Can Bitcoin Stabilize After Coming Under Pressure?

Stock News
·
Sep 25

Sunway Healthcare's Unit to Acquire Freehold Land in Related Party Deal

MT Newswires Live
·
Sep 25

Merck, Eisai Get FDA OK of Welireg/Lenvima Combo in Kidney Cancer

Dow Jones
·
Sep 25

No Fork Needed: Bitcoin Privacy Proposal Sparks Industry Debate

Stock News
·
Sep 25

Edible Garden Wins Third Walmart Distribution Center Award for Fresh Herbs

Reuters
·
Sep 25

Ocugen Wins Provisional Approval for Ocu400 in Bahamas Under LARTA Pathway

Reuters
·
Sep 25

Top Premarket Gainers

MT Newswires Live
·
Sep 25

Nektar Therapeutics - Jury Finds Lilly Breached Implied Covenant of Good Faith in License Agreement - SEC Filing

THOMSON REUTERS
·
Sep 25

Morgan Stanley Steps In: USDT Returns to Bitcoin Network via RGB Protocol

Stock News
·
Sep 25

Bitcoin Spot ETF Erases $5.8 Billion Loss as Bessent Policy Spurs $400 Million Inflow

Stock News
·
Sep 25

Fate Therapeutics Wins $15 Million CIRM Grant for FT819 Lupus Nephritis Phase 2 Trial

Reuters
·
Sep 25

SpaceX AI Will Pass Anthropic, OpenAI in 6 Months, Musk Says. What it Means for the Stock.

Dow Jones
·
Sep 25

Sernova, Seraxis Plan Merger to Form BetaNova Biotherapeutics

Reuters
·
Sep 25

MetaOptics Begins Trading on OTCQX After Upgrade from Pink Limited, OTC Markets Says

Reuters
·
Sep 25

Reborn Coffee Signs MOU with Visvita to Expand Franchise Supply Chain

Reuters
·
Sep 25

FactSet Appoints Former Robeco COO Marcel Prins to Board

Reuters
·
Sep 25

C4 Therapeutics Says Cemsidomide-Elranatamab Phase 1b Trial Clears 75 Μg Dose as Safe in Multiple Myeloma

Reuters
·
Sep 25

Trump wants to take a page out of the Biden energy playbook

CNN Business
·
Sep 25